New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 16, 2013
09:10 EDTCTXSCitrix shares should be bought ahead of Synergy event, says Pacific Crest
Pacific Crest recommends that investors buy shares of Citrix Systems ahead of its Syenrgy event, as the firm thinks that new products announced there will provide a positive catalyst for the shares. The firm sees multiple catalysts for the stock and keeps an Outperform rating on the shares.
News For CTXS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 25, 2015
11:43 EDTCTXSCitrix may not be for sale according to internal memo, Fortune reports
Subscribe for More Information
September 23, 2015
09:09 EDTCTXSOn The Fly: Pre-market Movers
HIGHER: Heron Therapeutics (HRTX), up 20% after announcing results from its Phase 2 clinical study of its drug for the management of post-operative pain in patients undergoing bunionectomy... BioMed Realty Trust (BMR), up 10% after Bloomberg reported that the company is in talks to sell itself and has attracted interest from companies including Blackstone (BX) and Canaccord upgraded BioMed Realty to Buy... Citrix Systems (CTXS), up 2.5% after Reuters said the company is making a last-ditch attempt to sell itself as a whole company before beginning asset sales. LOWER: OncoGenex (OGXI), down 19% after the company reported that the addition of apatorsen to Abraxane and gemcitabine did not demonstrate a survival benefit compared to Abraxane and gemcitabine alone in a Phase 2 clinical study... Pacira Pharmaceuticals (PCRX), down 3.7% in the wake of Heron's new data, with several analysts stating that Heron's data compares favorably versus Pacira's Exparel drug.
05:59 EDTCTXSCitrix again tries to sell itself, Reuters reports
Subscribe for More Information
September 22, 2015
08:04 EDTCTXSCitrix says Royal Caribbean deploys mobile workspace solution
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use